markets: We expect the coverage companies to clock in sales growth of 9.2% Y-o-Y (+2.5% Q-o-Q) in Q3FY24E. This should be aided by growth in India Pharma Market (IPM) which is expected to clock in ~8.6% Y-o-Y growth in Q3FY24 driven by recovery in Acute segment sales; partially offset by onset of festive season, destocking of channel inventory and high base effect in November 23.